Quillivant ER (methylphenidate HCl extended-release) chewable tablets are now available for treatment of attention deficit hyperactivity disorder in children ages six to 12.
The Ontario Pharmacists Association says a freedom of information request asking for pharmacy-level data on MedsChecks and other services is inappropriate. Do you agree?
Kristen Watt wrote about receiving a letter from a local physician notifying pharmacies that patients would be billed for mandatory paperwork related to Limited Use forms, substitutions due to back-orders and reviewing MedsChecks forms.
The Canadian Medical Association announced this year’s award recipients on Tuesday, honouring 13 individuals for their achievements, innovations and activism in the field of medicine.
